SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as SB-715992, work in different ways to stop tumor cells
from dividing so they stop growing or die. This phase II trial is studying how well SB-715992
works in treating patients with metastatic prostate cancer that did not respond to docetaxel
or paclitaxel